Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A. Iaccarino L, et al. Among authors: emmi g, emmi l. J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19. J Autoimmun. 2018. PMID: 28935492
The "multifaceted" onset of vasculitis neuropathy.
Emmi L, Squatrito D, Emmi G, Beccastrini E, Silvestri E. Emmi L, et al. Among authors: emmi g. Intern Emerg Med. 2013 Oct;8(7):551-2. doi: 10.1007/s11739-012-0894-6. Epub 2012 Dec 20. Intern Emerg Med. 2013. PMID: 23254469 No abstract available.
Anakinra for resistant Behçet uveitis: why not?
Emmi G, Silvestri E, Cameli AM, Bacherini D, Vannozzi L, Squatrito D, Emmi L. Emmi G, et al. Among authors: emmi l. Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):152-3. Epub 2013 Sep 9. Clin Exp Rheumatol. 2013. PMID: 24064028 No abstract available.
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets.
Beccastrini E, D'Elios MM, Emmi G, Silvestri E, Squatrito D, Prisco D, Emmi L. Beccastrini E, et al. Among authors: emmi g, emmi l. Int J Immunopathol Pharmacol. 2013 Jul-Sep;26(3):585-96. doi: 10.1177/039463201302600302. Int J Immunopathol Pharmacol. 2013. PMID: 24067455 Free article. Review.
Behçet's syndrome pathophysiology and potential therapeutic targets.
Emmi G, Silvestri E, Squatrito D, D'Elios MM, Ciucciarelli L, Prisco D, Emmi L. Emmi G, et al. Among authors: emmi l. Intern Emerg Med. 2014 Apr;9(3):257-65. doi: 10.1007/s11739-013-1036-5. Epub 2014 Jan 12. Intern Emerg Med. 2014. PMID: 24415351 Review.
326 results